SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: Manny Gugliuzza who wrote (1343)5/10/1999 11:54:00 PM
From: jake burns  Read Replies (1) | Respond to of 1510
 
hopefully, this link will work....this is huge for two reasons: first is the technology IRC just licensed; second is what it portends about the remune immunotherapeutic....the fact that Robert Gallo and imnr are collaborating means that imnr wants gallo, and gallo wants as well, to be the main frontman for remune....methinks this is extremely significant.

newsalert.com



To: Manny Gugliuzza who wrote (1343)5/11/1999 12:48:00 AM
From: Alex Glavinos  Read Replies (1) | Respond to of 1510
 
Manny, thanks, the news is great. It appears we may have a very good year. Cheers and good luck Remune, RA, and now IHV.